ICUI Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

160.615

Open

154.970

VWAP

157.62

Vol

347.98K

Mkt Cap

3.98B

Low

152.815

Amount

54.85M

EV/EBITDA(TTM)

15.52

Total Shares

24.99M

4.87B

EV/OCF(TTM)

29.10

P/S(TTM)

1.78

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.

Events Timeline

(ET)

2026-05-07

18:00:00

ICU Medical Reports Q1 Revenue of $530.23M

2026-02-19 (ET)

2026-02-19

16:30:00

Company Sees FY26 Adjusted EBITDA of $400M to $430M

2026-02-19

16:30:00

ICU Medical Reports Q4 Revenue of $540.7M

News

6.0

06-15CNBC

Latest Wall Street Ratings Overview

5.0

06-11NASDAQ.COM

ICU Medical VP Sells Shares Worth $304,000

5.0

06-11Fool

ICU Medical Executive Sells Shares, Impact on Holdings

6.0

05-27CNBC

Wall Street's Latest Rating Changes Overview

9.5

05-08seekingalpha

ICU Medical Q1 2026 Earnings Call Insights

9.5

04-23Newsfilter

ICU Medical Announces Q1 2026 Earnings Release Schedule

3 Analyst Rating

Wall Street analysts forecast ICUI stock price to rise

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

172.00

Averages

173.50

High

175.00

Current: 0.000

Low

172.00

Averages

173.50

High

175.00

BTIG

Buy

initiated

$170

AI Analysis

2026-06-15

Reason

BTIG

Price Target

$170

AI Analysis

2026-06-15

initiated

Buy

Reason

BTIG initiated coverage of ICU Medical with a Buy rating and $170 price target. ICU is a "pure-play infusion therapy company operating in one of healthcare's most structurally defensive markets," the analyst tells investors in a research note. The firm says that with 90% of hospitalized patients receiving IV therapy, ICU's "consumables-heavy model" generates predictable, recurring revenue, supporting a mid-single-digit organic growth profile. BTIG also sees upside opportunities, saying competitive disruption in the U.S. large volume pump market creates a near-term share capture window for ICU's Plum Duo and Solo platform.

Needham

Hold

Buy

upgrade

$165

2026-05-27

Reason

Needham

Price Target

$165

2026-05-27

upgrade

Hold

Buy

Reason

Needham upgraded ICU Medical to Buy from Hold with a $165 price target. The firm expects the company to benefit from an IV system replacement cycle as well as challenges at peers. ICU's exposure to higher oil prices is limited, and management expects favorable tariff changes and efficiencies to offset the impact, the analyst tells investors in a research note. Needham expects the company to continue to deliver "strong" margin improvement and sees share buybacks becoming another source of earnings growth as ICUI's leverage ratio declines and management begins to deploy free cash flow.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ICUI

Unlock Now

Valuation Metrics

The current forward P/E ratio for ICU Medical Inc (ICUI.O) is 18.98, compared to its 5-year average forward P/E of -22.03. For a more detailed relative valuation and DCF analysis to assess ICU Medical Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-22.03

Current PE

18.98

Overvalued PE

227.37

Undervalued PE

-271.42

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.94

Current EV/EBITDA

15.04

Overvalued EV/EBITDA

14.66

Undervalued EV/EBITDA

11.23

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.71

Current PS

1.75

Overvalued PS

2.25

Undervalued PS

1.17

Financials

AI Analysis

Annual

Quarterly

Whales Holding ICUI

Segall Bryant & Hamill, LLC

Fuller & Thaler Asset Management, Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is ICU Medical Inc (ICUI) stock price today?

The current price of ICUI is 159.43 USD — it has increased 2.88

What is ICU Medical Inc (ICUI)'s business?

What is the price predicton of ICUI Stock?

Wall Street analysts forecast ICUI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICUI is173.50 USD with a low forecast of 172.00 USD and a high forecast of 175.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.